https://www.insurerbrain.com/w/index.php?action=history&feed=atom&title=Definition%3AAntitrust_review_%28insurance%29 2026-06-14T05:41:47Z Revision history for this page on the wiki MediaWiki 1.43.8 https://www.insurerbrain.com/w/index.php?title=Definition:Antitrust_review_(insurance)&diff=10143&oldid=prev 2026-03-11T06:57:38Z

<p>Bot: Creating new article from JSON</p> <p><b>New page</b></p><div>📋 &#039;&#039;&#039;Antitrust review (insurance)&#039;&#039;&#039; is the regulatory scrutiny applied to insurance-sector mergers, acquisitions, and business combinations to determine whether they would substantially lessen competition or tend to create a monopoly in relevant insurance markets. While the [[Definition:McCarran-Ferguson Act | McCarran-Ferguson Act]] historically provided insurers with a limited exemption from federal antitrust law — deferring to state regulation — modern insurance M&amp;A transactions routinely face both federal review under the [[Definition:Hart-Scott-Rodino Act (HSR) | Hart-Scott-Rodino Act]] and state-level competitive analysis conducted by [[Definition:Insurance regulator | insurance regulators]] as part of the [[Definition:Regulatory approval (M&amp;A) | regulatory approval]] process.<br /> <br /> ⚙️ At the federal level, transactions exceeding the size-of-transaction thresholds set by the HSR Act require [[Definition:Pre-acquisition notification | pre-acquisition notification]] to the Federal Trade Commission and the Department of Justice, which then have a statutory waiting period to investigate competitive effects. Simultaneously, state insurance departments evaluate competitive impact through filings such as the [[Definition:Form E filing | Form E]], which specifically addresses whether the proposed acquisition would reduce the number of [[Definition:Insurance carrier | insurers]] competing in a given line of business or geographic market. Regulators examine [[Definition:Market share | market share]] data, [[Definition:Premium | premium]] concentration ratios, and the availability of substitute products, and they may block or condition a transaction that threatens meaningful competition.<br /> <br /> 🏛️ The dual federal-state structure of antitrust review creates a layered compliance challenge that is unique to insurance among financial services industries. A deal might clear federal review yet still face objections from a state regulator concerned about local market concentration in a specialty line such as [[Definition:Workers&#039; compensation insurance | workers&#039; compensation]] or [[Definition:Title insurance | title insurance]]. For acquirers — particularly [[Definition:Private equity | private equity]] sponsors assembling insurance platforms through roll-up strategies — mapping out potential antitrust friction early in the deal process helps avoid costly delays and can inform decisions about which targets to pursue or which product lines to divest.<br /> <br /> &#039;&#039;&#039;Related concepts:&#039;&#039;&#039;<br /> {{Div col|colwidth=20em}}<br /> * [[Definition:Hart-Scott-Rodino Act (HSR)]]<br /> * [[Definition:McCarran-Ferguson Act]]<br /> * [[Definition:Form E filing]]<br /> * [[Definition:Market concentration]]<br /> * [[Definition:Regulatory approval (M&amp;A)]]<br /> * [[Definition:Pre-acquisition notification]]<br /> {{Div col end}}</div>

PlumBot